Mohammed Riaz Ahmed, MD | |
415 S 28th Ave, Hattiesburg, MS 39401-7246 | |
(601) 288-4329 | |
(601) 288-3191 |
Full Name | Mohammed Riaz Ahmed |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 28 Years |
Location | 415 S 28th Ave, Hattiesburg, Mississippi |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942224514 | NPI | - | NPPES |
1501255 | Medicaid | LA | |
2399165 | Other | MS | UNITED HEALTHCARE |
009938623 | Medicaid | AL | |
05589211 | Medicaid | MS | |
640507572XG | Other | MS | AMERICAN ADMIN GROUP |
P00128951 | Other | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 18449 (Mississippi) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ingalls Memorial Hospital | Harvey, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Inpatient Consultants Of Illinois Pc | 9537064316 | 51 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Entity Name | Inpatient Consultants Of Illinois Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003850843 PECOS PAC ID: 9537064316 Enrollment ID: O20031204000698 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Entity Name | Cook County |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588612832 PECOS PAC ID: 2860398088 Enrollment ID: O20031209000747 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Entity Name | Mount Sinai Community Foundation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1376715896 PECOS PAC ID: 5991600405 Enrollment ID: O20040202001032 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Entity Name | Ipc Healthcare Services Of Illinois, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1215394861 PECOS PAC ID: 7810294188 Enrollment ID: O20160331001415 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Entity Name | Illinois Post-acute Medical Services 1 Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952830853 PECOS PAC ID: 6305112103 Enrollment ID: O20171023002483 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Entity Name | Hospitalist Physicians Of Illinois, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396347761 PECOS PAC ID: 0941614044 Enrollment ID: O20210202000124 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Mohammed Riaz Ahmed, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 579-5463 | Mohammed Riaz Ahmed, MD 415 S 28th Ave, Hattiesburg, MS 39401-7246 Ph: (601) 288-4329 |
News Archive
When the Northern Virginia Regional Health Information Organization (NoVaRHIO) goes live with its first major step towards an full scale interoperable eHealth Information Exchange (eHIE) connecting patients and physicians across the region, it will leverage GE Healthcare as a key infrastructure partner.
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy or blood — in use today.
Medivir AB, the emerging research-based specialty pharmaceutical company focused on infectious diseases announces today positive top-line 24-week interim data from the Phase 2b ASPIRE (C206) study of TMC435 in treatment-experienced hepatitis C patients.
CardioGenics Holdings Inc. announced today that it has been notified by the Canadian Intellectual Property Office that its patent application for the "core technology" utilized in its ultra-sensitive point-of-care immuno-analyzer, the QL Care Analyzer, has been granted. Patents covering the "core technology" have now been issued in Canada, the European Union and Japan.
A study of Swedish men suggests nine risk factors, most of which can be traced to adolescence, account for most cases of young-onset dementia (YOD) diagnosed before the age of 65 years, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
› Verified 3 days ago
Kabeer Burman, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-4329 Fax: 601-288-3191 | |
Mohammad Iffat Kabir Anindo, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-4329 Fax: 601-579-5240 | |
Manjunath Ramaiah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-4329 Fax: 601-288-3191 | |
George E Habeeb Jr., MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-4329 Fax: 601-288-3191 | |
Thomas E King Iii, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-4329 Fax: 601-288-3191 | |
Ralph C Kahler, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-296-2976 Fax: 601-579-5240 | |
Dr. Kelly W Ryder, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 415 S 28th Ave, Hattiesburg, MS 39401 Phone: 601-288-4329 |